Global Chondroitin and Hyaluronic Acid Sodium Injection Market Size, Share and Trends Analysis Report, By Type (Hyaluronic Acid Injection, Hyaluronic Acid Sodium), By Application (Beauty Industry, Medical Therapy), Forecast (2022-2028)

The global chondroitin and hyaluronic acid sodium injection market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Hyaluronic acid degrades during an injury, causing joint discomfort and inflammation in the ligaments and tendons that surround the joint. The geriatric population is highly prone to joint problems. The elderly population is rapidly increasing. More than millions of people are 65 or older, according to the United Nations. The elderly population is prone to joint pain and other diseases. People aged 65 and up are in poor physical condition. They are unable to regularly visit healthcare clinics and hospitals for health checks. As a result, the geriatric population can use joint pain injections on a large scale to avoid frequent hospital visits. As a result, the growing geriatric population is a key factor driving the growth of the global chondroitin and hyaluronic acid sodium injection market.

Allergan Plc, Galdermal, LG Life Science, Bohus Biotech, IMEIK, Bloomage Freda, Allergan, among others are making significant contribution to the global market by adoption of strategic market development activities including new product launches among others. For instance, in June 2020, AbbVie announced the approval of JuvedermVoluma XC, a new hyaluronic acid product indicated for improving chin profile in adults. TACTOSET, Anika Therapeutics’ first hyaluronic acid-based surgically delivered regenerative therapy, was launched in the US in December 2019 for the treatment of bone defects caused by trauma or degeneration. JUVÉDERM VOLUMA XC was approved by the FDA in September 2019 for use with the TSK STERiGLIDE cannula for cheek augmentation.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Allergan Plc, Galdermal, LG Life Science, Bohus Biotech, IMEIK, Bloomage Freda, Allergan, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Chondroitin and Hyaluronic Acid Sodium Injection Market Report by Segment

By Type

• Hyaluronic Acid Injection
• Hyaluronic Acid Sodium

By Application

• Beauty Industry
• Therapy

Global Chondroitin and Hyaluronic Acid Sodium Injection Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa